Effect of Butyrate Supplement on Rheumatoid Arthritis
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study is a pilot study to evaluate the safety and efficacy of administering butyrate
supplement on rheumatoid arthritis patients. Ten participants will be included to receive
butyrate supplement for 12 weeks. Changes of immune cell subtypes, markers of intestinal
damage, intestinal flora and other laboratory indicators will be monitored.